Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Health Policy

PIH40 What Do Health Economists Expect From Their Employer- Results From an On-Line Survey in Germany

Value in Health

English

Pmd184 - Po-Scorad Tool in Black Skin Patients With Atopic Dermatitis: Correlation With the Scorad

English

Prm74 - Clinical Outcome Assessments in Drug Approvals: A Review of Label Claims in the United States and Europe (2013-2017)

English

Prm97 - Patient Versus Treatment Line Level Matching: Impact on Covariates Balance and Cost Effectiveness Results, a Case Study in Oncology

English

Prs58 - Patients With Idiopathic Pulmonary Fibrosis (Ipf): What Happens Before the Diagnosis? A Real-World, Retrospective, Primary Care Database Analysis

English

Psy103 - Modelling Average Cost and Cost-Per-Responder for Biological Treatments for Moderate-To-Severe Plaque Psoriasis With Dose Escalation and Real-World Drug Survival

English

Puk16 - Cost-Effectiveness of Tolvaptan in Canadian Patients With Autosomal Polycystic Kidney Disease: An Adaptation of the Adpkd Outcomes Model

English

Pdb81 - Dapagliflozin Is Cost-Effective Compared to DPP-4 Inhibitors in the Treatment of Type 2 Diabetes Mellitus in the Netherlands

English

Pnd111 - Eliciting Preferences in Relapsing-Remitting Multiple Sclerosis – A Brazilian Study Using a Multicriteria Decision Analysis (Mcda) Approach

English

Prm245 - Extrapolation of Survival in the Context of Economic Modelling Using Bayesian Model Averaging: An Application in Renal Cell Carcinoma

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Health Policy

PIH40 What Do Health Economists Expect From Their Employer- Results From an On-Line Survey in Germany

Pmd184 - Po-Scorad Tool in Black Skin Patients With Atopic Dermatitis: Correlation With the Scorad

Prm74 - Clinical Outcome Assessments in Drug Approvals: A Review of Label Claims in the United States and Europe (2013-2017)

Prm97 - Patient Versus Treatment Line Level Matching: Impact on Covariates Balance and Cost Effectiveness Results, a Case Study in Oncology

Prs58 - Patients With Idiopathic Pulmonary Fibrosis (Ipf): What Happens Before the Diagnosis? A Real-World, Retrospective, Primary Care Database Analysis

Psy103 - Modelling Average Cost and Cost-Per-Responder for Biological Treatments for Moderate-To-Severe Plaque Psoriasis With Dose Escalation and Real-World Drug Survival

Puk16 - Cost-Effectiveness of Tolvaptan in Canadian Patients With Autosomal Polycystic Kidney Disease: An Adaptation of the Adpkd Outcomes Model

Pdb81 - Dapagliflozin Is Cost-Effective Compared to DPP-4 Inhibitors in the Treatment of Type 2 Diabetes Mellitus in the Netherlands

Pnd111 - Eliciting Preferences in Relapsing-Remitting Multiple Sclerosis – A Brazilian Study Using a Multicriteria Decision Analysis (Mcda) Approach

Prm245 - Extrapolation of Survival in the Context of Economic Modelling Using Bayesian Model Averaging: An Application in Renal Cell Carcinoma